EUVIMEDEUVIMED entdecken
Crossref

From salvage to spotlight: how 2025 transformed PSMA radioligand therapy

Abdullah Al-Khanaty, Carlos Delgado, Francisco Valencia, David Chen, Marlon L Perera, Renu Eapen, Arun A Azad iD, James P Buteau, Michael S Hofman iD, Declan G Murphy iD

BJU International · 14.04.2026

DOI: 10.1111/bju.70282 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BJU International, online erschienen am 14.04.2026. Verfasst von Abdullah Al-Khanaty und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Die Arbeit nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

lutetium 177precision oncologyprostate cancerprostate cancer theranosticsprostate‐specific membrane antigen radioligand therapyradiopharmaceutal therapyterbium 161treatment intensification

Autor:innen und Institutionen

  • Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Department of Surgery, Austin Health, University of Melbourne, Melbourne, Victoria, Australia.
  • Department of Urology, Salvador Zubrán National Institute of Health Sciences and Nutrition, Mexico City, Mexico.
  • Department of Molecular Imaging and Therapeutic Nuclear Medicine, Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC), Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.

ORCID-Profile: Arun A Azad, Michael S Hofman, Declan G Murphy

Zitieren

APA

Al-Khanaty, A., Delgado, C., Valencia, F., Chen, D., Perera, M. L., Eapen, R., Azad, A. A., Buteau, J. P., Hofman, M. S., & Murphy, D. G. (2026). From salvage to spotlight: how 2025 transformed PSMA radioligand therapy. BJU International. https://doi.org/10.1111/bju.70282

Vancouver

Al-Khanaty A, Delgado C, Valencia F, Chen D, Perera ML, Eapen R, et al. From salvage to spotlight: how 2025 transformed PSMA radioligand therapy. BJU International. 2026. doi:10.1111/bju.70282

BibTeX
@article{AlKhanaty2026,
  author = {Al-Khanaty, Abdullah and Delgado, Carlos and Valencia, Francisco and Chen, David and Perera, Marlon L and Eapen, Renu and Azad, Arun A and Buteau, James P and Hofman, Michael S and Murphy, Declan G},
  title = {From salvage to spotlight: how 2025 transformed PSMA radioligand therapy},
  journal = {BJU International},
  year = {2026},
  doi = {10.1111/bju.70282}
}
Kostenlos starten →